Reports

Global Recombinant DNA Technology Market to Reach USD 902 Billion by 2026, Aided by Growing R&D Activities

Recombinant DNA Technology Market

Global Recombinant DNA Technology Market Size, Forecast: By Product: Medical, Non-Medical; By Component: Expression System, Cloning Vector; By Application: Food and Agriculture, Health and Disease, Environment, Others; By End Use; Regional Analysis; Market Dynamics: SWOT Analysis; Competitive Landscape; 2024-2032

Global Recombinant DNA Technology Market Outlook

The global recombinant DNA Technology market attained a value of about USD 740.66 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 6.8% to reach nearly USD 1338.54 billion by 2032.

 

Global Recombinant DNA Technology Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Advancements in Technology Owing to Research and Development (R&D) is Expected to Augment the Market Growth

The growing research and development (R&D) activities to treat life threatening diseases like cancer, diabetes, and other  immunodeficiency diseases are expected to augment the market growth of recombinant DNA technology. Technology in collaboration with medicine has made it possible to treat diseases by inserting new or healthy genes in replacement of damaged or diseased genes in the human body. Recombinant DNA technology has allowed scientists to treat diabetes by developing human insulin by using bacteria as the host cell, with the drug produced through microbes thought to be more efficient than the traditional drug. Such developments are expected to aid the market growth. Moreover, advancements in recombinant technologies have also led to the development of gene therapies, used in the treatment of genetic diseases, which is further anticipated to bolster the recombinant DNA industry in the coming years.

 

Growing Use of Recombinant DNA Technology to Produce Transgenic Animals to Aid the Market Growth

The recombinant DNA technology can be applied to animals to produce transgenic animals. Transgenic animals provide tremendous opportunities to study gene regulation and disease. This is expected to strengthen the research and development (R&D) sector and, thereby, aid the market growth of recombinant DNA technology. Transgenic animals may be genetically modified for the production of pharmaceuticals and vaccine, thus, bolstering industrial demand for recombinant DNA technology due to a heightened demand for effective vaccines and new drugs globally.

 

Recombinant DNA Technology : Market Segmentation

Recombinant DNA technology (rDNA), also known as genetic engineering, is the technique in which the DNA is cut into small fragments and the joined together with different fragments taken from different organisms to form a recombinant DNA.  It comprises altering genetic material outside an organism to obtain desired and enhanced results in living organisms.

 

Global Recombinant DNA Technology Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on product, the market is divided into:

  • Medical 
  • Therapeutic Agent
  • Human Protein
  • Vaccine
  • Non-Medical
  • Biotech Crops
  • Speciality Chemicals
  • Others

On the basis of component, the market is segmented into:

  • Expression System
  • Mammalian
  • Bacteria
  • Yeast
  • Baculovirus/Insect
  • Cloning Vector

Based on application, the market is divided into:

  • Food and Agriculture
  • Health and Disease
  • Human
  • Animal
  • Environment
  • Others

On the basis of end use, the market is categorised into:

  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutions
  • Others

The EMR report looks into the regional markets of recombinant DNA technology like North America, Europe, Latin America, the Asia Pacific, and the Middle East and Africa.

 

Global Recombinant DNA Technology Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF


Use of Recombinant DNA technology in Food & Agricultural Sector to Surge Industrial Growth

Recombinant DNA technology has shown promising results in the agricultural sector in the production of genetically modified crops. The wide availability of genetically modified foods in the market owing to increased overall production of crops  and reduced used of herbicides and insecticides used by farmers has been strengthening the market growth of recombinant DNA technology. The technology has introduced herbicide bacterial genes into the DNA of certain crops like wheat, soybean, cotton, and rice, making the plant resistant to weeds and insects and making the yield toxic free. This is supporting agricultural productivity and, thus, increasing the demand for recombinant DNA technology. The added benefit of reduced costs with the use of recombinant DNA technology in the agricultural sector is expected to further propel the industrial growth.

Moreover, the cultivation of vitamin-A rich golden rice using recombinant DNA technology to treat malnourished children is expected to further invigorate the market growth in the coming years. Further, with the rising research and development activities related to genetically modified crops, these crops can possess the ability to withstand adverse environmental conditions, such as drought and extreme heat conditions. This is anticipated to provide further growth opportunities for the recombinant DNA technology industry, especially with the growing concerns about climate change and global warming.

 

Key Industry Players in the Global Recombinant DNA Technology Market

The report presents a detailed analysis of the following key players in the global recombinant DNA technology market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions.

  • Sanofi
  • Amgen Inc.
  • Genentech Inc.
  • GenScript
  • Profacgen
  • Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

 

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Component, Application, End Use, Region
Breakup by Product Medical, Non-Medical
Breakup by Component Expression System, Cloning Vector
Breakup by Application Food and Agriculture, Health and Disease, Environment, Others
Breakup by End Use Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Sanofi, Amgen Inc., Genentech Inc., GenScript, Profacgen., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface   
2    Report Coverage – Key Segmentation and Scope
3    Report Description
    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary
    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Recombinant DNA Technology Market Analysis
    8.1    Key Industry Highlights
    8.2    Global Recombinant DNA Technology Historical Market (2018-2023) 
    8.3    Global Recombinant DNA Technology Market Forecast (2024-2032)
    8.4    Global Recombinant DNA Technology Market by Product
        8.4.1    Medical
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
            8.4.1.3    Breakup by Type
                8.4.1.3.1    Therapeutic Agent
                    8.4.1.3.1.1     Historical Trend (2018-2023)
                    8.4.1.3.1.2     Forecast Trend (2024-2032)
                8.4.1.3.2    Human Protein
                    8.4.1.3.2.1     Historical Trend (2018-2023)
                    8.4.1.3.2.2     Forecast Trend (2024-2032)
                8.4.1.3.3    Vaccine
                    8.4.1.3.3.1     Historical Trend (2018-2023)
                    8.4.1.3.3.2     Forecast Trend (2024-2032)
        8.4.2    Non-Medical
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
            8.4.2.3    Breakup by Type
                8.4.2.3.1    Biotech Crops
                    8.4.2.3.1.1     Historical Trend (2018-2023)
                    8.4.2.3.1.2     Forecast Trend (2024-2032)
                8.4.2.3.2    Speciality Chemicals
                    8.4.2.3.2.1     Historical Trend (2018-2023)
                    8.4.2.3.2.2     Forecast Trend (2024-2032)
                8.4.2.3.3    Others
    8.5    Global Recombinant DNA Technology Market by Component
        8.5.1    Expression System
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
            8.5.1.3    Breakup by Type
                8.5.1.3.1    Mammalian
                    8.5.1.3.1.1     Historical Trend (2018-2023)
                    8.5.1.3.1.2     Forecast Trend (2024-2032)
                8.5.1.3.2    Bacteria
                    8.5.1.3.2.1     Historical Trend (2018-2023)
                    8.5.1.3.2.2     Forecast Trend (2024-2032)
                8.5.1.3.3    Yeast
                    8.5.1.3.3.1     Historical Trend (2018-2023)
                    8.5.1.3.3.2     Forecast Trend (2024-2032)
                8.5.1.3.4    Baculovirus/Insect
                    8.5.1.3.4.1     Historical Trend (2018-2023)
                    8.5.1.3.4.2     Forecast Trend (2024-2032)
        8.5.2    Cloning Vector
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
    8.6    Global Recombinant DNA Technology Market by Application
        8.6.1    Food and Agriculture
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Health and Disease
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
            8.6.2.3    Breakup by Type
                8.6.2.3.1    Human
                    8.6.2.3.1.1     Historical Trend (2018-2023)
                    8.6.2.3.1.2     Forecast Trend (2024-2032)
                8.6.2.3.2    Animal
                    8.6.2.3.2.1     Historical Trend (2018-2023)
                    8.6.2.3.2.2     Forecast Trend (2024-2032)
        8.6.3    Environment
            8.6.3.1    Historical Trend (2018-2023)
            8.6.3.2    Forecast Trend (2024-2032)
        8.6.4    Others
    8.7    Global Recombinant DNA Technology Market by End Use
        8.7.1    Biotechnology and Pharmaceutical Companies
            8.7.1.1    Historical Trend (2018-2023)
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Academic and Government Research Institutes
            8.7.2.1    Historical Trend (2018-2023)
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Others    
    8.8    Global Recombinant DNA Technology Market by Region
        8.8.1    North America
            8.8.1.1    Historical Trend (2018-2023) 
            8.8.1.2    Forecast Trend (2024-2032)
        8.8.2    Europe
            8.8.2.1    Historical Trend (2018-2023) 
            8.8.2.2    Forecast Trend (2024-2032)
        8.8.3    Asia Pacific
            8.8.3.1    Historical Trend (2018-2023) 
            8.8.3.2    Forecast Trend (2024-2032)
        8.8.4    Latin America
            8.8.4.1    Historical Trend (2018-2023) 
            8.8.4.2    Forecast Trend (2024-2032)
        8.8.5    Middle East and Africa
            8.8.5.1    Historical Trend (2018-2023) 
            8.8.5.2    Forecast Trend (2024-2032) 
9    North America Recombinant DNA Technology Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Recombinant DNA Technology Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Recombinant DNA Technology Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.2    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Recombinant DNA Technology Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Recombinant DNA Technology Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape
    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Sanofi
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Amgen Inc.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Genentech Inc.
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    GenScript
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Profacgen.
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Others
17    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Recombinant DNA Technology Market: Key Industry Highlights, 2018 and 2032
2.    Global Recombinant DNA Technology Historical Market: Breakup by Product (USD Billion), 2018-2023
3.    Global Recombinant DNA Technology Market Forecast: Breakup by Product (USD Billion), 2024-2032
4.    Global Recombinant DNA Technology Historical Market: Breakup by Component Type (USD Billion), 2018-2023
5.    Global Recombinant DNA Technology Market Forecast: Breakup by Component Type (USD Billion), 2024-2032
6.    Global Recombinant DNA Technology Historical Market: Breakup by Application (USD Billion), 2018-2023
7.    Global Recombinant DNA Technology Market Forecast: Breakup by Application (USD Billion), 2024-2032
8.    Global Recombinant DNA Technology Historical Market: Breakup by End-Use (USD Billion), 2018-2023
9.    Global Recombinant DNA Technology Market Forecast: Breakup by End-Use (USD Billion), 2024-2032
10.    Global Recombinant DNA Technology Historical Market: Breakup by Region (USD Billion), 2018-2023
11.    Global Recombinant DNA Technology Market Forecast: Breakup by Region (USD Billion), 2024-2032
12.    North America Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2018-2023
13.    North America Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2024-2032
14.    Europe Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2018-2023
15.    Europe Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2024-2032
16.    Asia Pacific Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2018-2023
17.    Asia Pacific Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2024-2032
18.    Latin America Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2018-2023
19.    Latin America Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2024-2032
20.    Middle East and Africa Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2018-2023
21.    Middle East and Africa Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2024-2032
22.    Global Recombinant DNA Technology Equipment Market Structure

Key Questions Answered in the Report

What was the global recombinant DNA technology market size in 2023?

The market attained a value of nearly USD 740.66 billion in 2023.

What is the growth rate of the global recombinant DNA technology market?

The market is projected to grow at a CAGR of 6.8% in the forecast period of 2024-2032.

What is the forecast outlook of the market for 2024-2032?

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 1338.54 billion by 2032.

What are the major drivers of the market?

The major market drivers include rapid technological advancements and the growing research and development (R&D) programmes for the treatment of life-threatening diseases like cancer and diabetes.

What are the key industry trends of the global recombinant DNA technology market?

The growing deployment of recombinant DNA technology in the agricultural sector, the wide availability of genetically modified foods, and the surging R&D activities related to genetically modified crops are the key trends fuelling the market demand.

What are the major regional markets of recombinant DNA technology, according to the EMR report?

The major regional markets for recombinant DNA technology are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

What are the major products considered in the market report?

The major products considered in the market report are medical and non-medical.

What are the significant components of recombinant DNA technology in the market?

The significant components of recombinant DNA technology include expression system and cloning vector.

What are the various applications of recombinant DNA technology?

The various applications of recombinant DNA technology are food and agriculture, health and disease, and environment, among others.

What are the several end uses of recombinant DNA technology?

The several end uses of recombinant DNA technology are biotechnology and pharmaceutical companies and academic and government research institutes, among others.

Who are the key market players, according to the report?

The major players in the recombinant DNA technology market are Sanofi, Amgen Inc., Genentech Inc., GenScript, and Profacgen, among others.

Analyst Review

The global recombinant DNA technology market attained a value of nearly USD 740.66 billion in 2023, driven by rapid technological advancements. Aided by the growing use of rDNA technology in the food and agricultural sector, the industry is further expected to grow at a CAGR of 6.8% in the forecast period 2024-2032 to reach USD 1338.54 billion by 2032.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of product, the market is divided into medical and non-medical. Medical products are further divided into therapeutic agent, human protein, and vaccine. Non-medical products are further segmented into biotech crops, speciality chemicals, and others. Based on component type, the market is divided into expression system and cloning vector. Expression system is further divided into mammalian, bacteria, yeast, and baculovirus/insect. On the basis of application, the market is divided into food and agriculture, health and disease, environment, and others. Health and disease is further categorised into human and animal. Based on end use, the market is segmented into biotechnology and pharmaceutical companies, academic and government research institutions, and others. The major regional markets for recombinant DNA technology are North America, Latin America, the Asia Pacific, Europe and the Middle East and Africa. The key players in the above market are Sanofi, Amgen Inc., Genentech Inc., GenScript, and Profacgen , among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Single User License

$2799
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now
most popular

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER